SCHEMBL24920893

SCHEMBL24920893

COc1nccc(-c2nnc(C)o2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 1/20 0.45
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
PDPK1 O15530 1/20 0.38
BRD4 O60885 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
MAPK14 Q16539 2/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
NOTUM Q6P988 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SYK P43405 1/20 0.32
TLR8 Q9NR97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24921172 0.77 CCR1 (0.59) PTGDRCCR1CCR5CCR8MAPK14
SCHEMBL14031549 0.75 PDPK1 (0.40) PIM1PIM2PDPK1BRD4MAPK9
SCHEMBL24920772 0.74 NOTUM (0.45) PIM1PIM2PDPK1CCR1CCR5
SCHEMBL24920894 0.74 ACHE (0.40) PTGDRPDPK1CCR1CCR5CCR8
SCHEMBL24921979 0.73 PTGDR (0.39) PTGDRBRD4NOTUMNPC1RAB9A
SCHEMBL24921468 0.72 PTGDR (0.36) PTGDRBRD4MAPK14NOTUMNPC1
SCHEMBL24920898 0.72 PDPK1 (0.39) PIM1PIM2PDPK1MAPK9MAPK10
SCHEMBL24921174 0.72 PIM1 (0.43) PTGDRPIM1PIM2BRD4
SCHEMBL17253104 0.72 PDPK1 (0.39) PIM1PIM2PDPK1CCR1CCR5
SCHEMBL24920805 0.71 KDM4E (0.43) PIM1PDPK1NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed